Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−28.72 M USD
33.49 M USD
12.44 M
About Artiva Biotherapeutics, Inc.
Sector
Industry
CEO
Fred Aslan
Website
Headquarters
San Diego
Founded
2019
FIGI
BBG00VPZJ0F9
Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ARTV is 10.96 USD — it has increased by 4.58% in the past 24 hours. Watch Artiva Biotherapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Artiva Biotherapeutics, Inc. stocks are traded under the ticker ARTV.
ARTV stock has risen by 6.41% compared to the previous week, the month change is a −0.90% fall, over the last year Artiva Biotherapeutics, Inc. has showed a −31.50% decrease.
We've gathered analysts' opinions on Artiva Biotherapeutics, Inc. future price: according to them, ARTV price has a max estimate of 23.00 USD and a min estimate of 18.00 USD. Watch ARTV chart and read a more detailed Artiva Biotherapeutics, Inc. stock forecast: see what analysts think of Artiva Biotherapeutics, Inc. and suggest that you do with its stocks.
ARTV reached its all-time high on Oct 1, 2024 with the price of 17.31 USD, and its all-time low was 9.68 USD and was reached on Oct 31, 2024. View more price dynamics on ARTV chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ARTV stock is 11.58% volatile and has beta coefficient of 1.25. Track Artiva Biotherapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Artiva Biotherapeutics, Inc. there?
Today Artiva Biotherapeutics, Inc. has the market capitalization of 266.21 M, it has decreased by −5.07% over the last week.
Yes, you can track Artiva Biotherapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Artiva Biotherapeutics, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
ARTV earnings for the last quarter are −0.92 USD per share, whereas the estimation was −0.84 USD resulting in a −10.16% surprise. The estimated earnings for the next quarter are −0.76 USD per share. See more details about Artiva Biotherapeutics, Inc. earnings.
Artiva Biotherapeutics, Inc. revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of 100.00 K USD. In the next quarter, revenue is expected to reach 75.00 K USD.
ARTV net income for the last quarter is −17.47 M USD, while the quarter before that showed −17.84 M USD of net income which accounts for 2.08% change. Track more Artiva Biotherapeutics, Inc. financial stats to get the full picture.
No, ARTV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 77.00 employees. See our rating of the largest employees — is Artiva Biotherapeutics, Inc. on this list?
Like other stocks, ARTV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Artiva Biotherapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.